Not applicableUnknownNCT02717936What this trial is testingInvestigation of Desmoplastic Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of the Skin University Hospital Tuebingen 73
Not applicableLooking for participantsNCT07403630What this trial is testingINTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)Who this might be right forAcute LeukemiaMultiple MyelomaSquamous Cell Carcinoma+9 more Azienda Ospedaliero-Universitaria di Parma 300
Early research (Phase 1)Study completedNCT03195699What this trial is testingOral STAT3 Inhibitor, TTI-101, in Patients With Advanced CancersWho this might be right forBreast CancerHead and Neck Squamous Cell CarcinomaNon Small Cell Lung Cancer+5 more Tvardi Therapeutics, Incorporated 64
Early research (Phase 1)Study completedNCT05577182What this trial is testingStudy of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced MalignanciesWho this might be right forAdvanced Malignancies Incyte Corporation 46
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT04045496What this trial is testingA First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsWho this might be right forNon-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more Jacobio Pharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06223659What this trial is testingEMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin CancersWho this might be right forCutaneous MelanomaMerkel Cell CarcinomaSkin Squamous Cell Carcinoma Ohio State University Comprehensive Cancer Center 100
Not applicableStudy completedNCT03026361What this trial is testingMolecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral CavityWho this might be right forOral Lichen PlanusOral Squamous Cell Carcinoma University of Zagreb 71
Early research (Phase 1)Temporarily pausedNCT03970382What this trial is testingGene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsWho this might be right forSolid Tumor PACT Pharma, Inc. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05070403What this trial is testingStudy of Afatinib in Advanced Cutaneous Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma H. Lee Moffitt Cancer Center and Research Institute 35
Early research (Phase 1)Looking for participantsNCT06451497What this trial is testingThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsWho this might be right forNon Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaPancreas Adenocarcinoma+8 more Zumutor Biologics Inc. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642What this trial is testingA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Who this might be right forUterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more GV20 Therapeutics 227
Not applicableActive Not RecruitingNCT05323253What this trial is testingAlpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell CarcinomaWho this might be right forRecurrent Squamous Cell Carcinoma Alpha Tau Medical LTD. 86
Testing effectiveness (Phase 2)Looking for participantsNCT05706129What this trial is testingAssess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more Lumara Bio Oncologics GmbH 270
Testing effectiveness (Phase 2)Looking for participantsNCT04114136What this trial is testingAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesWho this might be right forMelanomaNSCLCHepatocellular Carcinoma+5 more Dan Zandberg 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140500What this trial is testingDose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid TumorsWho this might be right forSolid TumorsMetastatic MelanomaNon-small Cell Lung Cancer+1 more Hoffmann-La Roche 170
Early research (Phase 1)Study completedNCT03829436What this trial is testingTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersWho this might be right forHepatocellular CarcinomaMetastatic Castration Resistant Prostate CancerRenal Cell Carcinoma+9 more Tempest Therapeutics 38
Not applicableStudy completedNCT04308616What this trial is testingUtility of Squamous Cell Carcinoma Antigen (SCCA) in PsoriasisWho this might be right forPsoriasis University Hospital, Tours 51
Not applicableActive Not RecruitingNCT06014619What this trial is testingComplications and Recurrences After Mohs Micrographic Surgery and Slow MohsWho this might be right forSkin CancerComplicationComplication of Surgical Procedure+7 more Maastricht University Medical Center 500
Early research (Phase 1)Active Not RecruitingNCT05891171What this trial is testingStudy of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersWho this might be right forAdvanced CancerAdvanced MalignanciesBladder Cancer+9 more Arcus Biosciences, Inc. 40